Balchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026
Rhea-AI Summary
Balchem (NASDAQ: BCPC) will participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026. Senior management attendees include Ted Harris (Chairman, President & CEO), Martin Bengtsson (CFO) and Allison Baurichter (Senior Director, Investor Relations).
The company will present and engage with investors at the industry conference, offering updates on strategy and market positioning for health and nutrition ingredients.
Positive
- None.
Negative
- None.
News Market Reaction – BCPC
In the Feb 24 session, BCPC gained 1.64%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 20 | Earnings results | Positive | -3.6% | Record 2025 sales, EBITDA and free cash flow with higher EPS and dividend. |
| Feb 06 | Earnings call setup | Neutral | -0.3% | Announcement of Q4 and full-year 2025 earnings call and webcast details. |
| Jan 02 | Conference participation | Neutral | +0.4% | Participation in CJS virtual conference to discuss strategy with investors. |
| Dec 22 | Regulatory update | Positive | +0.5% | EU anti-dumping duties on Chinese choline chloride supporting EU producers. |
| Dec 10 | Dividend increase | Positive | +2.4% | Annual dividend raised 10.3%, seventeenth consecutive yearly increase. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows generally positive reactions to capital return and regulatory wins, while strong earnings in Feb 2026 saw a short-term pullback despite record results.
Over the past few months, Balchem reported record 2025 sales and earnings, raised its dividend for a seventeenth consecutive year, and highlighted supportive EU anti-dumping measures on choline chloride. It also maintained an active investor-relations schedule with conferences and earnings calls. Against that backdrop, this JP Morgan forum appearance continues a pattern of regular engagement with investors rather than marking a new fundamental development.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTVALE, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
Contact: Jacqueline Yarmolowicz
Balchem Corporation (Telephone: 845-326-5600)
